|
Market Closed -
Nasdaq
23:00:00 16/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.110 USD | -1.77% |
|
-5.13% | -52.36% |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.81M | - | - | - | - | - |
| 69.18B | |||||
| 62B | |||||
| 26.19B | - | ||||
| 25.75B | |||||
| 24.29B | - |
Select your edition
All financial news and data tailored to specific country editions
